The role of Interleukin-6 (IL-6) has also recently been investigated as a mechanistic explanation driving increased odds of DKA, as IL-6 levels are elevated in both DKA and COVID-19 [21], although this finding may only have prognostic relevance. The gene discussed is IL6; the disease is COVID-19.